Distinct signatures of the immune responses in low risk versus high risk neuroblastoma

BACKGROUND: Over 90% of low risk (LR) neuroblastoma patients survive whereas less than 30% of high risk (HR) patients are long term survivors. Age (children younger than 18 months old) is associated with LR disease. Considering that adaptive immune system is well developed in older children, and tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Gowda, Madhu, Godder, Kamar, Kmieciak, Maciej, Worschech, Andrea, Ascierto, Maria-Libera, Wang, Ena, Marincola, Francesco M, Manjili, Masoud H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195752/
https://www.ncbi.nlm.nih.gov/pubmed/21978632
http://dx.doi.org/10.1186/1479-5876-9-170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195752/
https://www.ncbi.nlm.nih.gov/pubmed/21978632
http://dx.doi.org/10.1186/1479-5876-9-170

Ejemplares similares